Skip Navigation


European Heart Journal Advance Access originally published online on April 7, 2009
European Heart Journal 2009 30(12):1457-1466; doi:10.1093/eurheartj/ehp110
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
30/12/1457    most recent
ehp110v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mehran, R.
Right arrow Articles by Ohman, E. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mehran, R.
Right arrow Articles by Ohman, E. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org

Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial

Roxana Mehran1,*, Stuart J. Pocock2, Gregg W. Stone1, Tim C. Clayton2, George D. Dangas1, Frederick Feit3, Steven V. Manoukian4, Eugenia Nikolsky1, Alexandra J. Lansky1, Ajay Kirtane1, Harvey D. White5, Antonio Colombo6, James H. Ware7, Jeffrey W. Moses1 and E. Magnus Ohman8

1 Columbia University Medical Center and Cardiovascular Research Foundation, 161 Fort Washington Avenue, 5th Floor, New York, NY 10032, USA
2 London School of Hygiene and Tropical Medicine, London, UK
3 New York University School of Medicine, New York, NY, USA
4 Emory University School of Medicine, Atlanta, GA, USA
5 Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand
6 San Raffaele Scientific Institute, Milan, Italy
7 Harvard School of Public Health, Boston, MA, USA
8 Duke University School of Medicine, Durham, NC, USA

Received 23 May 2008; revised 16 February 2009; accepted 4 March 2009; online publish-ahead-of-print 7 April 2009.

* Corresponding author. Tel: +1 212 851 9303, Fax: +1 212 851 9300, Email: rmehran{at}crf.org

Aims: To evaluate the associations of myocardial infarction (MI) and major bleeding with 1-year mortality. Both MI and major bleeding predict 1-year mortality in patients presenting with acute coronary syndrome (ACS). However, the risk of each of these events on the magnitude and timing of mortality has not been well studied.

Methods and Results: A multivariable Cox regression model was developed relating 13 independent baseline predictors to 1-year mortality for 13 819 patients with moderate and high-risk ACS enrolled in the Acute Catheterization and Urgent Intervention Triage strategy trial. After adjustment for baseline predictors, Cox models with major bleeding and recurrent MI as time-updated covariates estimated the effect of these events on mortality hazard over time. Within 30 days of randomization, 705 patients (5.1%) had an MI, 645 (4.7%) had a major bleed; 524 (3.8%) died within a year. The occurrence of an MI was associated with a hazard ratio of 3.1 compared with patients not yet having an MI, after adjustment for baseline predictors. However, MI within 30 days markedly increased the mortality risk for the first 2 days after the event (adjusted hazard ratio of 17.6), but this risk declined rapidly post-infarct (hazard ratio of 1.4 beyond 1 month after the MI event). In contrast, major bleeding had a prolonged association with mortality risk (hazard ratio of 3.5) which remained fairly steady over time throughout 1 year.

Conclusion: After accounting for baseline predictors of mortality, major bleeds and MI have similar overall strength of association with mortality in the first year after ACS. MI is correlated with a dramatic increase in short-term risk, whereas major bleeding correlates with a more prolonged mortality risk.

Key Words: Acute coronary syndrome • Myocardial infarction • Mortality • Bleeding • Transfusion


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
NEJMHome page
A. Kastrati and G. Ndrepepa
Cangrelor -- A Champion Lost in Translation?
N. Engl. J. Med., November 15, 2009; (2009) NEJMe0910677v1.
[Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
S. J. Brener
Antithrombin Therapy for Elective Percutaneous Coronary Intervention: Which Agent to Use? Does It Matter?
J. Am. Coll. Cardiol. Intv., November 1, 2009; 2(11): 1092 - 1094.
[Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
R. Mehran, E. Nikolsky, A. J. Lansky, A. J. Kirtane, Y.-H. Kim, F. Feit, S. Manoukian, J. W. Moses, R. Ebrahimi, E. M. Ohman, et al.
Impact of Chronic Kidney Disease on Early (30-Day) and Late (1-Year) Outcomes of Patients With Acute Coronary Syndromes Treated With Alternative Antithrombotic Treatment Strategies: An ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Substudy
J. Am. Coll. Cardiol. Intv., August 1, 2009; 2(8): 748 - 757.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.